Clinical Study Results Sanofi Pharma, including Sanofi Genzyme

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter G

Generic Name Trade Name Condition Study Code Study Name Access to study Access to results
GEMIGLIPTIN Zemiglo Diabetes Mellitus, Type 2 GEMIGL07185 NA NCT02343926
GLIMEPIRIDE Amaryl Diabetes Mellitus, Type 2 EFC10846 NA NCT00924573
GLIMEPIRIDE Amaryl Diabetes Mellitus, Type 2 GLIME_L_04140 SUMER NCT00957060
GLIMEPIRIDE Amaryl Diabetes Mellitus, Type 2 GLIME_L_04409 GREAT NCT00908921
GLIMEPIRIDE Amaryl Diabetes Mellitus, Type 2 HOE490_4038 NA NCT00353691
GLIMEPIRIDE Amaryl Diabetes Mellitus, Type 2 HOE490B_4001 NA NCT00633425
GLIMEPIRIDE Amaryl Diabetes Mellitus, Type 2 GLIME_R_05809 RECOMMEND NCT01459809
GLIMEPIRIDE - METFORMIN combination Amaryl-M Diabetes Mellitus, Type 2 GLMET_L_04735 DIAGRAM NCT01204580
GLIMEPIRIDE - METFORMIN combination Amaryl-M Diabetes Mellitus, Type 2 EFC11761 NA NCT01457911
GLIMEPIRIDE - METFORMIN combination Amaryl-M Diabetes Mellitus, Type 2 GLMET_R_05823 LEGEND NCT01699932

References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted